Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and its incidence and prevalence are increasing year by year. Atrial fibrillation mainly increases the risk of stroke by 2 to 7 times, increases the risk of death by 2 times, and seriously endangers the health of the population. Catheter ablation is currently the most effective method for the treatment of atrial fibrillation. Several randomized controlled trials have demonstrated that catheter ablation is more effective than antiarrhythmic drug therapy for maintaining sinus rhythm in both paroxysmal and persistent atrial fibrillation. 3D EP The Navigation System is one of the core devices for catheter ablation surgery.
This report contains market size and forecasts of 3D EP Navigation Systems in global, including the following market information:
Global 3D EP Navigation Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 3D EP Navigation Systems Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five 3D EP Navigation Systems companies in 2021 (%)
The global 3D EP Navigation Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Contact Mapping Navigation System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 3D EP Navigation Systems include Biosense Webster (Johnson & Johnson MedTech), BIOTRONIK, Boston Scientific, Medtronic, Abbott, Acutus Medical, Philips, MappingLab and APN Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 3D EP Navigation Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 3D EP Navigation Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 3D EP Navigation Systems Market Segment Percentages, by Type, 2021 (%)
Non-Contact Mapping Navigation System
Contact Mapping Navigation System
Global 3D EP Navigation Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 3D EP Navigation Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals
Medical Research Institute
Others
Global 3D EP Navigation Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 3D EP Navigation Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 3D EP Navigation Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 3D EP Navigation Systems revenues share in global market, 2021 (%)
Key companies 3D EP Navigation Systems sales in global market, 2017-2022 (Estimated), (K Units)
Key companies 3D EP Navigation Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biosense Webster (Johnson & Johnson MedTech)
BIOTRONIK
Boston Scientific
Medtronic
Abbott
Acutus Medical
Philips
MappingLab
APN Health
Microport EP Medtech
Apt Medical Inc.
Jinjiang Electronic Science and Technology